Today: 8 February 2026
Subscribe
Browse Category

Earnings Reports News 21 January 2026 - 22 January 2026

Lam Research stock climbs as Deutsche Bank lifts target ahead of Jan. 28 earnings

Lam Research stock climbs as Deutsche Bank lifts target ahead of Jan. 28 earnings

Lam Research shares rose 2.6% to $228.39 in after-hours trading Wednesday after multiple analysts raised price targets ahead of next week’s earnings. Analysts cited strong demand and accelerated chip equipment orders, with Deutsche Bank, UBS, and Needham all boosting targets and maintaining Buy ratings. Applied Materials, KLA, and ASML shares also gained. Lam reports results Jan. 28.
22 January 2026
··
Johnson & Johnson stock price swings late as JNJ guidance beats views, but talc risk grabs traders again

Johnson & Johnson stock price swings late as JNJ guidance beats views, but talc risk grabs traders again

Johnson & Johnson shares slipped 0.05% to $218.01 in after-hours trading Wednesday after the company projected 2026 sales and profits above Wall Street estimates. Investors weighed the upbeat forecast against renewed legal risks as a court-appointed special master recommended allowing expert testimony in federal talc litigation involving over 67,500 lawsuits. J&J plans to appeal the ruling.
22 January 2026
···
Manulife sets earnings date — and analysts are rethinking MFC’s value

Manulife sets earnings date — and analysts are rethinking MFC’s value

Manulife Financial will release fourth-quarter and full-year 2025 earnings after markets close Feb. 11, with a webcast and call set for Feb. 12. Shares closed at CA$50.63 after falling 2.9% in one day and 0.9% over the past week. Analysts have revised price targets ahead of the update. The stock trades at a price-to-earnings ratio of 15.7, above the sector average.
22 January 2026
·····
Eli Lilly stock rises as FDA gives ‘Breakthrough’ tag to ovarian cancer drug, earnings date set

Eli Lilly stock rises as FDA gives ‘Breakthrough’ tag to ovarian cancer drug, earnings date set

Eli Lilly shares rose 3.6% to $1,078.52 Wednesday after the FDA granted Breakthrough Therapy designation to its ovarian cancer drug candidate, sofetabart mipitecan. The company will report fourth-quarter earnings on February 4. Director Juan R. Luciano disclosed acquiring about 15 shares through deferred board compensation.
21 January 2026
···
Intel stock jumps 12% ahead of earnings as Nvidia export bill raises new AI-stock risk

Intel stock jumps 12% ahead of earnings as Nvidia export bill raises new AI-stock risk

Intel shares surged 11.7% to $54.25 in after-hours trading ahead of Thursday’s earnings report, as LSEG data pointed to a possible 30% jump in data-center revenue to $4.43 billion. Options markets signal an expected 8% move in the stock by week’s end. Nvidia, AMD, and Arm also rose, while U.S. lawmakers advanced a bill to tighten AI chip exports to China, targeting Nvidia’s Blackwell chips.
21 January 2026
······
Netflix stock slips after hours as $82.7 billion Warner Bros bid steals focus from earnings

Netflix stock slips after hours as $82.7 billion Warner Bros bid steals focus from earnings

Netflix shares dropped 2.2% to $85.36 in after-hours trading after announcing fourth-quarter revenue of $12.05 billion and an $82.7 billion all-cash bid for Warner Bros Discovery. Warner Bros Discovery shares rose 1% to $28.53, above Netflix’s $27.75-per-share offer. Paramount Skydance’s $30-per-share tender offer expires Jan. 21. Warner shareholders are expected to vote on the Netflix deal by April.
21 January 2026
····
Microsoft stock price slides after analyst target cuts as Wall Street braces for earnings

Microsoft stock price slides after analyst target cuts as Wall Street braces for earnings

Microsoft shares fell 2.7% to $442.45 in late trading Wednesday, underperforming tech peers ahead of next week’s earnings report. Several analysts trimmed price targets, citing concerns over short-term cloud and AI demand. Trading volume reached 26.6 million shares, above the 65-day average. Investors await Azure growth figures and initial Copilot revenue on Jan. 28.
21 January 2026
···
Broadcom stock dips again after Tuesday rout as VMware OneGov deal lands; earnings date in focus

Broadcom stock dips again after Tuesday rout as VMware OneGov deal lands; earnings date in focus

Broadcom shares fell 1.1% to $328.80 Wednesday after a 5.43% drop the previous day, as tariff threats and margin concerns rattled tech stocks. The U.S. GSA approved a OneGov deal with Broadcom, cutting prices on VMware and security software by up to 64% through May 2027. Trading volume reached about 31.7 million shares. Broadcom reports earnings March 4.
21 January 2026
···
AMD stock price jumps nearly 8% as board move and earnings countdown pull in buyers

AMD stock price jumps nearly 8% as board move and earnings countdown pull in buyers

AMD shares surged 7.8% to close at $250.02 Wednesday, outpacing the chip sector after Wall Street rebounded from a selloff. The company named former Accenture CFO KC McClure to its board and Audit and Finance Committee, granting her 1,278 restricted stock units. Traders are watching Intel’s earnings Thursday, with AMD set to report Feb. 3. Options volume on AMD more than doubled the daily average.
21 January 2026
···
Starbucks stock climbs as BofA lifts target; SBUX earnings on Jan. 28 in focus

Starbucks stock climbs as BofA lifts target; SBUX earnings on Jan. 28 in focus

Starbucks shares rose 2.5% to $95.99 Wednesday, outpacing the S&P 500 ahead of next week’s earnings report. Bank of America Securities raised its price target to $114, citing store traffic and margin improvements. Investors are watching for signs of a turnaround, with first-quarter results due Jan. 28. CEO Brian Niccol said no broad menu price hikes are planned for 2026.
21 January 2026
·
Dell stock rebounds after Morgan Stanley warning as Citi stays positive ahead of earnings

Dell stock rebounds after Morgan Stanley warning as Citi stays positive ahead of earnings

Dell shares rose 2.7% to $114.03 Wednesday, rebounding after a 7.85% drop Tuesday following a Morgan Stanley sector downgrade. Morgan Stanley cut its price target to $111 and kept an Underweight rating, while Citi lowered its target to $165 but maintained a Buy. Investors weighed analyst concerns over weak 2026 hardware budgets and rising component costs ahead of Dell’s Feb. 26 earnings report.
21 January 2026
··
Charles Schwab stock rises after earnings; Fed decision and crypto plans come next

Charles Schwab stock rises after earnings; Fed decision and crypto plans come next

Schwab shares rose about 1.5% after reporting a 19% jump in fourth-quarter net revenue to $6.34 billion and record core net new assets of $163.9 billion. Net interest revenue surged over 25% to $3.17 billion. CEO Rick Wurster said spot Bitcoin and Ethereum trading is still planned for the first half of 2026. Total client assets reached $11.90 trillion.
21 January 2026
····
Union Pacific stock jumps 3% as earnings near and Norfolk Southern merger reset stays in focus

Union Pacific stock jumps 3% as earnings near and Norfolk Southern merger reset stays in focus

Union Pacific shares rose about 3% to $228.42 Wednesday as rail stocks rallied ahead of the company’s Jan. 27 earnings release. Regulators last week ordered Union Pacific and Norfolk Southern to revise their $85 billion merger filing, citing missing details. The Surface Transportation Board set a Feb. 17 deadline for the companies to respond. CSX and Norfolk Southern shares also gained nearly 3%.
21 January 2026
···
Booking Holdings (BKNG) stock climbs as it sets Feb. 18 earnings date — what traders watch next

Booking Holdings (BKNG) stock climbs as it sets Feb. 18 earnings date — what traders watch next

Booking Holdings shares rose 1.4% to $5,096 on Wednesday after the company set February 18 for its Q4 and full-year 2025 earnings release. The stock traded between $5,009 and $5,108 during the session. Analysts expect quarterly earnings per share of $48.59 on $6.12 billion in revenue. Tuesday’s close was $5,027, down 1.74% and 14% below the 52-week high.
21 January 2026
··
Abbott (ABT) stock price ticks higher as heart-device news lands ahead of earnings — what investors watch

Abbott (ABT) stock price ticks higher as heart-device news lands ahead of earnings — what investors watch

Abbott Laboratories shares rose 0.2% to $121.34 midday Wednesday, lagging broader healthcare gains ahead of Thursday’s earnings report. The company secured EU clearance for its TactiFlex Duo ablation catheter and announced a partnership with AtaCor Medical to develop an extravascular defibrillator. Investors await guidance on 2026 and updates on the $21 billion Exact Sciences acquisition.
21 January 2026
··
1 … 68 69 70 71 72 … 203

Stock Market Today

China Life Insurance Class A stock (601628) slips — what to watch before Shanghai reopens

China Life Insurance Class A stock (601628) slips — what to watch before Shanghai reopens

8 February 2026
Shanghai, February 8, 2026, 07:41 CST — Market closed. China Life Insurance Co Ltd’s Shanghai-listed A-shares (601628) ended Friday down 0.75% at 47.47 yuan. Mainland markets are closed over the weekend and reopen on Monday. (Yahoo Finance) A-shares are yuan-denominated mainland listings, and big insurers can trade like rate stocks because they sit on large bond portfolios. Moves in yields and equities can shift investment income and the value of holdings. That puts focus on next week’s China inflation readings. The National Bureau of Statistics is scheduled to publish January consumer and producer inflation on Feb. 11, a release investors
Deutsche Telekom stock slips despite fresh buyback — what matters before earnings

Deutsche Telekom stock slips despite fresh buyback — what matters before earnings

8 February 2026
Deutsche Telekom shares fell 1.1% to 30.26 euros Friday, despite the company repurchasing 250,873 shares for about 7.63 million euros on Xetra. The drop came as European stocks rose and T-Mobile US shares slipped 2.2%. Deutsche Telekom’s 2025 results are due Feb. 26. The company has completed its 2025 buyback and launched a new 2 billion euro programme for 2026.
Airbus stock price ends higher near 191 euros as January deliveries slow, earnings loom

Airbus stock price ends higher near 191 euros as January deliveries slow, earnings loom

8 February 2026
Airbus shares rose 0.94% to 191.30 euros Friday as the company reported 19 aircraft deliveries in January, down from 25 a year earlier. Supply chain bottlenecks remain an issue, with executives at the Singapore Airshow calling delays “unacceptable.” Jefferies kept a Neutral rating and a 215-euro price target. Airbus will report full-year 2025 results on Feb. 19.
Go toTop